Browse by Audience
MEMBER

Update Your Profile
Member Spotlights
Refer a Member: IASP Champions
Join a Special Interest Group (SIG)
Find a Chapter
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Papers of the Week
Webinars and Podcasts
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Webinars & Podcasts
Curricula
Graduate Opportunities
Events

PATIENT & CAREGIVER

RELIEF News
Resources for Living with Pain
Global Alliance of Partners in Pain Advocacy (GAPPA)
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner

gy2022-1-3
I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Locking down the CGRP pathway during the COVID-19 pandemic lockdown: the PandeMig study.

< BACK TO ARCHIVE


2020 Oct 01


Neurol Sci


http://www.ncbi.nlm.nih.gov/pubmed/33001407?dopt=Abstract

Locking down the CGRP pathway during the COVID-19 pandemic lockdown: the PandeMig study.

Authors

Locking down the CGRP pathway during the COVID-19 pandemic lockdown: the PandeMig study.
Altamura C, Cevoli S, Aurilia C, Egeo G, Fofi L, Torelli P, Brunelli N, Pierangeli G, Favoni V, Fallacara A, Pensato U, Barbanti P, Vernieri F
Neurol Sci. 2020 Oct 01.
PMID: 33001407.

Abstract

The COVID-19 pandemic and the consequent lockdown came as a storm disrupting people's everyday life. This study aimed at observing whether the COVID-19 related lockdown influenced migraine frequency and disability in migraine patients on therapy with monoclonal antibodies inhibiting the CGRP pathway.
Read This Paper